Stay updated on Effect of Dupilumab on Contact Dermatitis: Clinical Trial
Sign up to get notified when there's something new on the Effect of Dupilumab on Contact Dermatitis: Clinical Trial page.

Latest updates to the Effect of Dupilumab on Contact Dermatitis: Clinical Trial page
- ChecktodayChange DetectedThe new screenshot shows minor updates, including a refreshed 'Last Update' timestamp and some formatting tweaks; core study details (title, purpose, arms, eligibility, and locations) appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedMajor addition of a government funding notice and upgrade to v3.2.0, replacing v3.1.0; references to operating status and status inquiries are now present.SummaryDifference4%

- Check29 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.1%

- Check43 days agoChange DetectedRevision: v3.0.2 (replacement for v3.0.1) is now shown; the Back to Top element has been removed.SummaryDifference0.2%

- Check50 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.2%

- Check58 days agoChange DetectedThe web page has updated its facility name and location details, while also removing specific location terms and previous revision information. The addition of 'dupilumab' and 'Skin and Connective Tissue Diseases' suggests a focus on new treatment options or areas of specialization.SummaryDifference3%

Stay in the know with updates to Effect of Dupilumab on Contact Dermatitis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Effect of Dupilumab on Contact Dermatitis: Clinical Trial page.